CJC-1295 is currently not approved by the FDA for clinical use in humans. It is primarily used for research purposes, and its use in clinical settings remains limited to experimental studies. There are ongoing investigations into its effects, but more robust human trials are required to confirm its safety and efficacy.
https://www.fda.gov/drugs/human-drug-compounding/safety-risks-associated-certain-bulk-drug-substances-nominated-use-compounding
https://www.fda.gov/media/94155/download